183 related articles for article (PubMed ID: 28058780)
1. Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.
Abo Youssef N; Schneider MP; Mordasini L; Ineichen BV; Bachmann LM; Chartier-Kastler E; Panicker JN; Kessler TM
BJU Int; 2017 Apr; 119(4):515-521. PubMed ID: 28058780
[TBL] [Abstract][Full Text] [Related]
2. Intravesical vanilloids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2018 Jan; 37(1):67-82. PubMed ID: 28618110
[TBL] [Abstract][Full Text] [Related]
3. Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Tornic J; Sartori AM; Gajewski JB; Cox A; Schneider MP; Youssef NA; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2018 Nov; 37(8):2315-2322. PubMed ID: 29917273
[TBL] [Abstract][Full Text] [Related]
4. Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Schneider MP; Tornic J; Sýkora R; Abo Youssef N; Mordasini L; Krhut J; Chartier-Kastler E; Davies M; Gajewski J; Schurch B; Bachmann LM; Kessler TM
Neurourol Urodyn; 2019 Aug; 38(6):1482-1491. PubMed ID: 31099113
[TBL] [Abstract][Full Text] [Related]
5. Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
Schneider MP; Gross T; Bachmann LM; Blok BF; Castro-Diaz D; Del Popolo G; Groen J; Hamid R; Karsenty G; Pannek J; Hoen L'; Kessler TM
Eur Urol; 2015 Nov; 68(5):859-67. PubMed ID: 26194043
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
Gross T; Schneider MP; Bachmann LM; Blok BF; Groen J; Hoen LA; Castro-Diaz D; Padilla Fernández B; Del Popolo G; Musco S; Hamid R; Ecclestone H; Karsenty G; Phé V; Pannek J; Kessler TM
Eur Urol; 2016 Jun; 69(6):1102-11. PubMed ID: 26831506
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin for treating nocturia in patients with multiple sclerosis: A systematic review: A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS).
Phé V; Schneider MP; Peyronnet B; Abo Youssef N; Mordasini L; Chartier-Kastler E; Bachmann LM; Kessler TM
Neurourol Urodyn; 2019 Feb; 38(2):563-571. PubMed ID: 30653737
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis.
Torres-Moreno MC; Papaseit E; Torrens M; Farré M
JAMA Netw Open; 2018 Oct; 1(6):e183485. PubMed ID: 30646241
[TBL] [Abstract][Full Text] [Related]
9. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review.
Musco S; Padilla-Fernández B; Del Popolo G; Bonifazi M; Blok BFM; Groen J; 't Hoen L; Pannek J; Bonzon J; Kessler TM; Schneider MP; Gross T; Karsenty G; Phé V; Hamid R; Ecclestone H; Castro-Diaz D
Neurourol Urodyn; 2018 Jun; 37(5):1522-1540. PubMed ID: 29392753
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of the neuro-urological patient: a systematic review.
Averbeck MA; Madersbacher H
BJU Int; 2015 Apr; 115 Suppl 6():39-46. PubMed ID: 25891319
[TBL] [Abstract][Full Text] [Related]
11. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
[TBL] [Abstract][Full Text] [Related]
12. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Cheng T; Shuang WB; Jia DD; Zhang M; Tong XN; Yang WD; Jia XM; Li S
PLoS One; 2016; 11(7):e0159307. PubMed ID: 27463810
[TBL] [Abstract][Full Text] [Related]
14. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.
Brady CM; DasGupta R; Dalton C; Wiseman OJ; Berkley KJ; Fowler CJ
Mult Scler; 2004 Aug; 10(4):425-33. PubMed ID: 15327041
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder.
Tsang B; Stothers L; Macnab A; Lazare D; Nigro M
Neurourol Urodyn; 2016 Mar; 35(3):354-64. PubMed ID: 25620137
[TBL] [Abstract][Full Text] [Related]
16. Symptom management.
O'Connor P
Adv Neurol; 2006; 98():227-55. PubMed ID: 16400837
[No Abstract] [Full Text] [Related]
17. Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
De Ridder D; Van Der Aa F; Debruyne J; D'hooghe MB; Dubois B; Guillaume D; Heerings M; Ilsbroukx S; Medaer R; Nagels G; Seeldrayers P; Van Landegem W; Willekens B; Zicot AF
Clin Neurol Neurosurg; 2013 Oct; 115(10):2033-40. PubMed ID: 23880016
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
Bosma R; Wynia K; Havlíková E; De Keyser J; Middel B
Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Denys P; Phe V; Even A; Chartier-Kastler E
Ann Phys Rehabil Med; 2014 Jul; 57(5):297-301. PubMed ID: 24958444
[TBL] [Abstract][Full Text] [Related]
20. Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Scheepe JR; Wong YY; van Pelt ED; Ketelslegers IA; Catsman-Berrevoets CE; van den Hoek J; Hintzen RQ; Neuteboom RF
Mult Scler; 2016 Oct; 22(11):1490-1494. PubMed ID: 26589894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]